drugset / Trial / NCT02095860

Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325

NCT02095860

Phase 1 Completed 24 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to assess the effect of a high fat meal and light meal on the blood levels of Daclatasvir, Asunaprevir and BMS-791325 after administration of the 3 drugs as a fixed-dose combination in healthy subjects.

Timeline

Start
2014-04
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Asunaprevir Small molecule Oral
Subject Beclabuvir Small molecule Oral
Subject Daclatasvir Small molecule Oral